SMLR Sees Significant Bullish Activity with Surging Call Options | SMLR Stock News

Author's Avatar
Jun 06, 2025

Semler Scientific (SMLR, Financial) has experienced a notable uptick in bullish option activity, with 3,718 call contracts being traded, surpassing the expected volume by a factor of 1.2. The implied volatility for these options has risen by over one point, reaching 90.06%. Investors are particularly focused on the Dec-25 95 call options and the Jun-25 40 call options, with these two strikes accounting for nearly 1,900 contracts in total volume. The Put/Call Ratio stands at a remarkably low 0.04, indicating a strong bullish sentiment among traders.

Wall Street Analysts Forecast

1931054019401379840.png

Based on the one-year price targets offered by 1 analysts, the average target price for Semler Scientific Inc (SMLR, Financial) is $71.00 with a high estimate of $71.00 and a low estimate of $71.00. The average target implies an upside of 113.73% from the current price of $33.22. More detailed estimate data can be found on the Semler Scientific Inc (SMLR) Forecast page.

Based on the consensus recommendation from 1 brokerage firms, Semler Scientific Inc's (SMLR, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.

SMLR Key Business Developments

Release Date: May 13, 2025

  • Total Revenue: $8.8 million in Q1 2025, down 44% compared to Q1 2024.
  • Operating Expenses: $39.9 million in Q1 2025, including a $29.8 million contingency reserve for DOJ settlement.
  • Loss from Operations: $31.1 million in Q1 2025, compared to income from operations of $7 million in Q1 2024.
  • Net Loss: $64.7 million or $6.74 per share in Q1 2025, compared to net income of $6.1 million or $0.88 per share in Q1 2024.
  • Bitcoin Holdings: 3,808 bitcoins valued at approximately $400 million, with a net unrealized fair value gain of $59 million.
  • Cash, Cash Equivalents, and Restricted Cash: $9.9 million as of March 31, 2025.
  • Convertible Note Financing: $100 million raised in Q1 2025, primarily used for bitcoin purchases.
  • ATM Program: $500 million program effective April 22, 2025, with $61 million raised through May 12.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

  • Semler Scientific Inc (SMLR, Financial) has successfully acquired 3,808 bitcoins, valued at approximately $400 million, making it the fourth largest bitcoin treasury company in the US.
  • The company achieved a 152.8% positive bitcoin yield since adopting bitcoin as its primary treasury reserve asset, resulting in significant gains.
  • Semler Scientific Inc (SMLR) has ambitious plans to further increase its bitcoin holdings with a new $500 million ATM program.
  • The company is diversifying its customer base and introducing additional FDA-cleared products in the cardiovascular space, which shows potential for future growth.
  • Despite challenges, the company's stock has appreciated 64% in less than 12 months, outperforming the S&P 500's 9% increase.

Negative Points

  • Total revenues in Q1 2025 were $8.8 million, down about 44% compared to the first quarter of 2024.
  • Operating expenses in Q1 2025 increased significantly to $39.9 million, including a $29.8 million contingency reserve related to a DOJ settlement.
  • The company reported a net loss of $64.7 million for Q1 2025, compared to a net income of $6.1 million in Q1 2024.
  • There was a net unrealized loss of $41.8 million from the change in fair value of bitcoin holdings, introducing volatility to reported net income.
  • The healthcare business faced pressure from CMS payment changes, impacting revenue and requiring strategic adjustments to maintain operations.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.